Date | Title | Description |
31.10.2024 | The Rise of Biomarkers: Navigating the Future of Personalized Medicine | In the realm of healthcare, biomarkers are the new compass. They guide us through the complex landscape of disease and treatment. As we delve deeper into the world of biomarkers, particularly protein biomarkers, we uncover their potential t... |
30.10.2024 | Managing Scientific Risks in Dermatology Trials, Upcoming Webinar Hosted by Xtalks | www.ppd.com
In this free webinar, explore the nature and utility of scientific surveillance in the context of clinical trials. Attendees will review the specific aspects of scientific surveillance in dermatology clinical trials vs the broad... |
23.10.2024 | Three Transformative Strategies to Accelerate Clinical Trials in The Modern World, Upcoming Webinar Hosted by Xtalks | www.ppd.com
In this free webinar, learn three transformative strategies to expedite clinical trials, ensure faster time-to-market and enhanced patient outcomes. Attendees will learn how leveraging comprehensive contract research organizatio... |
18.10.2024 | The Digital Revolution in Clinical Trials: A New Era of Efficiency and Preparedness | In the world of clinical research, time is of the essence. Every moment counts. The landscape is changing rapidly, driven by technology and the pressing need for efficiency. Two recent webinars highlight this shift: one focuses on digitized... |
17.10.2024 | Pandemic Preparedness: Agility in Vaccine, Diagnostics and Therapeutics Development, Upcoming Webinar Hosted by Xtalks | www.ppd.com
In this free webinar, learn about the importance of pandemic preparedness and how it can be achieved. Attendees will learn what it takes to manufacture pharmaceutical products and launch clinical trials during a public health em... |
16.10.2024 | Optimizing Clinical Trial Protocols: How Digitized Protocols are Accelerating Clinical Research, Upcoming Webinar Hosted by Xtalks | www.ppd.com
In this free webinar, gain insights into protocol digitization, understand how it can drive efficiencies and discover how it can elevate clinical trials. Attendees will learn about the value of digitized protocols and gain an un... |
08.10.2024 | How Decentralized and Rapid NGS Testing Can Overcome Challenges in Oncology Trials, Upcoming Webinar Hosted by Xtalks | www.ppd.com
In this free webinar, learn the key challenges and complexities with oncology biomarker-driven clinical trials. Attendees will learn key considerations when managing oncology biomarker-driven trials. The featured speakers will d... |
01.10.2024 | Mastering Scope 3 Emissions in Clinical Trials: Strategic Partnerships for Supporting Business-Critical Sustainability Plans, Upcoming Webinar Hosted by Xtalks | https://www.scoutclinical.com/
In this free webinar, learn what sponsors and contract research organizations (CROs) require from a Scope 3 provider and the challenges they face. Attendees will learn strategies to reduce emissions without co... |
23.09.2024 | Charting the Course: Strategies for Therapeutic Vaccine Study Success, Upcoming Webinar Hosted by Xtalks | www.ppd.com
In this free webinar, learn about current therapeutic vaccine research focusing on cancer and infectious disease indications. Attendees will gain insights into the unique requirements and best practices in therapeutic vaccine st... |
20.09.2024 | Navigating the Frontiers of Cancer Research: The 12th Annual Virtual Event by Labroots | The fight against cancer is a relentless battle. Each year, researchers and medical professionals gather to share insights, breakthroughs, and strategies. On October 2, 2024, Labroots will host its 12th Annual Cancer Research & Oncology... |
16.09.2024 | Maximizing Patient Recruitment in Rare Neurological Clinical Studies, Upcoming Webinar Hosted by Xtalks | www.ppd.com
In this free webinar, learn about the specific challenges associated with recruiting participants for rare neurological clinical studies. Attendees will learn effective strategies for reducing site start-up time. The featured sp... |
11.09.2024 | Global R&D Insights in Drug Development: Insights from Industry on the Future of Pharma, Upcoming Webinar Hosted by Xtalks | www.ppd.com/
In this free webinar, learn about the latest trends in drug discovery and development, including key therapeutic areas, technological advancements and innovative strategies that are driving transformation in the pharmaceutical ... |
11.09.2024 | Shifting Ophthalmology Retina Market: Proactive Planning for Late-Stage Clinical Success, Upcoming Webinar Hosted by Xtalks | www.ppd.com
In this free webinar, learn why, despite the development of numerous novel treatments in ophthalmology, there is still a significant need for more cost-effective and patient-friendly options. The featured speakers will discuss h... |
05.09.2024 | Patient First: Enhancing Strategies for Effective Patient Engagement, Recruitment and Diversity in Clinical Trials, Upcoming Webinar Hosted by Xtalks | www.ppd.com
In this webinar, learn innovative approaches to tailor recruitment efforts to prioritize patient needs and preferences, including strategies to improve representation from underrepresented groups. Attendees will understand the i... |
03.09.2024 | ProofPilot Bolsters Advisory Board with Appointment of Michelle Everill | NEW YORK, Sept. 3, 2024 /PRNewswire/ -- ProofPilot, the leading Clinical Experience Platform (CXP) that centralizes and simplifies communication for sponsors, patients, and sites across the clinical trial experience, welcomes the addition o... |
17.08.2024 | The Weight of Change: Understanding Sarcopenia in the Age of GLP-1 Therapies | In the realm of weight loss, the conversation is shifting. Once dominated by the scale, it now embraces the complexity of body composition. At the forefront of this evolution are GLP-1 receptor agonists, a class of medications that promise ... |
14.08.2024 | Sarcopenia: Changes and Challenges in Body Composition with GLP-1 Receptor Agonist-based Weight Loss Therapies, Upcoming Webinar Hosted by Xtalks | www.ppd.com
In this free webinar, learn about the impact of GLP-1 receptor agonist-based therapies on skeletal muscle. Attendees will learn how weight loss-induced sarcopenia affects health and quality of life, especially in elderly persons... |
16.05.2024 | Leveraging AI for Clinical Trial Efficiencies, Upcoming Webinar Hosted by Xtalks | www.ppd.com
In this free webinar, learn how the PPD clinical research business of Thermo Fisher Scientific is at the forefront of applying artificial intelligence (AI) to clinical trials in the focus areas of clinical site selection, foreca... |
23.04.2024 | Key Considerations for Cell Therapy Trials Beyond Oncology, Upcoming Webinar Hosted by Xtalks | www.ppd.com
In this free webinar, learn the essential infrastructure requirements necessary for clinical sites to effectively manage cell therapy products in non-oncology clinical trials. Attendees will learn the key considerations in patie... |
22.04.2024 | Moody's: Don't expect many large health deals in 2024 | figcaption>span]:font-sans">
Anyone hoping for merger madness in health care this year will have to defer those dreams, a recent Moody's report suggests.
The big picture: Transformative M&A, particularly in the payer and prov... |
16.04.2024 | AHP Backed Prolerity Clinical Research Appoints Drew Domescik as CFO | NEW YORK, April 16, 2024 /PRNewswire/ -- Prolerity Clinical Research ("Prolerity), a clinical research site network and an AHP portfolio company, announced today that it has appointed Drew Domescik as Chief Financial Officer. Prolerity... |
12.03.2024 | Real World Evidence/RWE Solutions Market is growing at a CAGR of 13.8% from 2024 to 2030 by Exactitude Consultancy | Real World Evidence (RWE) Solutions market
The Exactitude Consultancy Real World Evidence/RWE Solutions Market Report – Size, Trends, and Forecast 2024-2030
The Real World Evidence (RWE) Solutions market is experiencing high demand due to i... |
17.07.2023 | Optimizing Medical Information Technology to Improve the Customer Experience, Upcoming Webinar Hosted by Xtalks | Xtalks Life Science Webinars The webinar will provide guidance on cutting through the noise of new medical information technology offerings.
Toronto, ON (PRWEB) July 17, 2023
In the rapidly changing landscape of medical information technolo... |
12.07.2023 | Intelligent Drug Development: A New Service Paradigm for Small Pharma, Upcoming Webinar Hosted by Xtalks | Xtalks Life Science Webinars This strategy focuses on Phases I and II, aiming to achieve proof-of-concept as efficiently as possible, completing all learning required to plan a comprehensive and effective Phase III program.
TORONTO (PRWEB) ... |
29.06.2023 | Rare Disease Trials and Gene Therapy: Understanding the Patient Journey, Upcoming Webinar Hosted by Xtalks | It also will shed light on the importance of incorporating patient feedback into protocol design, recognizing it as a critical step in advancing these therapies.
TORONTO (PRWEB) June 29, 2023
In a rapidly advancing field of medical science,... |
06.06.2023 | Oncology Clinical Trials: Solving Complex Challenges with Data-Driven and Innovative Approaches, Upcoming Webinar Hosted by Xtalks | Join this webinar to discover how data-driven and innovative approaches help tackle complex challenges in oncology clinical trials.
TORONTO (PRWEB) June 06, 2023
Oncology clinical trials face many challenges today, especially in the context... |
26.05.2023 | Menarini Group Shares New Analysis from EMERALD Clinical Study of ORSERDU® (Elacestrant) in Metastatic Breast Cancer at ASCO 2023 | ORSERDU (elacestrant) was approved by the FDA in January 2023 for estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer with ESR1-mutations (ESR1-mut) that are found i... |
22.05.2023 | Patient Centricity in Clinical Trials — The Trinity of Patient, Sites and Sponsors, Upcoming Webinar Hosted by Xtalks | The inclusion of flexible remote and televisits facilitates higher participation as it reduces the need for family/caregiver assistance, time off work and childcare assistance.
TORONTO (PRWEB) May 22, 2023
Patient-centricity and patient div... |
09.05.2023 | Menarini Group Announces New Data on Elacestrant at 2023 ESMO Breast Cancer Congress and 2023 ASCO Annual Meeting | FLORENCE, Italy and NEW YORK, May 9, 2023 /PRNewswire/ -- The Menarini Group ("Menarini"), a leading Italian pharmaceutical and diagnostics company, and Stemline Therapeutics ("Stemline"), a wholly-owned subsidiary of th... |
04.05.2023 | Reducing Caregiver Burden in Alzheimer’s Disease Clinical Trials to Boost Patient Recruitment, Upcoming Webinar Hosted by Xtalks | During a clinical trial the ‘caregiver’ becomes the ‘study partner’ and is essential for the success of clinical research.
TORONTO (PRWEB) May 04, 2023
Caregivers play a critical role in clinical research since they are the closest and most... |
31.10.2022 | The Changing Face of Trial Recruitment: Site-Only and Recruitment Provider Options, Upcoming Webinar Hosted by Xtalks | Effective communications can result in better selected study sites and drive trial recruitment and patient retention, saving time and money in clinical trials.
TORONTO (PRWEB) October 31, 2022
Competition within the drug development industr... |
17.10.2022 | Pandemic Preparedness & Rapid Response — Managing Clinical Research During a Public Health Emergency, Upcoming Webinar Hosted by Xtalks | Learn what hurdles must be overcome while conducting effective clinical research in a pandemic scenario, and the advantages of having an established pandemic preparedness and rapid response model in place.
TORONTO (PRWEB) October 17, 2022
T... |
18.07.2022 | Diversity and Inclusion in Clinical Trials — Practical Steps for Patient Recruitment Strategies, Upcoming Webinar Hosted by Xtalks | In this webinar, hear: What diversity and inclusion in clinical trials mean, not just from the US, but also from a global perspective.
Toronto, ON (PRWEB) July 18, 2022
In April 2022, the US Food and Drug Administration (FDA) published a gu... |
09.02.2022 | Heart Failure with Preserved Ejection Fraction (HFpEF) — Clues to the Identification of Undiagnosed Patients, Upcoming Webinar Hosted by Xtalks | Join this insightful webinar to also hear about a critical new finding which the featured speakers believe will be of value to the audience, including clinicians caring for patients with HFpEF and scientists seeking new avenues for investig... |
28.09.2021 | First-in-Class, Broad-Spectrum Nasal Spray to Prevent COVID-19 and Other Common Respiratory Illnesses Set to Begin Phase 2 Trials | — ENA Respiratory engages PPD, Inc. for Phase 2 COVID-19 post-exposure prophylaxis study and hVIVO for influenza challenge study to assess the efficacy of fast-acting nasal spray designed to boost innate immunity |
15.04.2021 | Medable Raises $78M to Expand Decentralized Clinical Trials Platform for Patient-Centered Drug Development | What You Should Know:
– Medable, Inc., a Palo Alto, CA-based global platform for decentralized clinical trials today announced $78M in new funding to fuel advances in the delivery of digital and decentralized clinical trials, accelerating t... |
15.04.2021 | Thermo Fisher Scientific to Acquire PPD, Inc., a Leading Clinical Research Organization | April 15th, 2021
WALTHAM, Mass. and WILMINGTON, N.C.
Further expands service offering to pharma and biotech customers
Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”), the world leader in serving science, and PPD, Inc. (Nasdaq... |
15.04.2021 | Thermo Fisher Scientific to Acquire PPD, Inc., a Leading Clinical Research Organization | |
15.04.2021 | Thermo Fisher Scientific : to Acquire PPD, Inc., a Leading Clinical Research Organization | WALTHAM, Mass. and WILMINGTON, N.C., April 15, 2021 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO) ("Thermo Fisher"), the world leader in serving science, and PPD, Inc. (Nasdaq: PPD) ("PPD"), a leading global ... |
17.03.2021 | PPD Named a Leader in Digital Clinical Trial Solutions by ISG | WILMINGTON, N.C.--(BUSINESS WIRE)--Mar 17, 2021--
PPD, Inc. (Nasdaq: PPD ), a leading global contract research organization, has been recognized for industry leadership in digital and decentralized clinical trial solutions by Information Se... |
20.11.2020 | Medable Raises $91M for Global Decentralized Clinical Trials Platform | What You Should Know:
Medable announced $91 million in new funding to accelerate the life sciences industry’s shift to digital and decentralized clinical trials, bringing Medable’s total capital raised to more than $136M.
– Medable has play... |
04.05.2020 | Medable Secures $25M Funding To Reduce Clinical Trial Timelines | 44 Shares Email Facebook Twitter LinkedIn
Palo Alto, California startup Medable Inc. raised $25 million in funding led by GSR Ventures, to accelerate clinical drug development with digital technology.
Subscribe to the Crunchbase Daily
Found... |
04.05.2020 | Medable Secures $25M Funding To Reduce Clinical Trial Timelines | 43 Shares Email Facebook Twitter LinkedIn
Palo Alto, California startup Medable Inc. raised $25 million in funding led by GSR Ventures, to accelerate clinical drug development with digital technology.
Subscribe to the Crunchbase Daily
Found... |
- | PPD Reports Fourth Quarter and Full Year 2020 Results | WILMINGTON, N.C.--(BUSINESS WIRE)--Feb 23, 2021--
PPD, Inc. (Nasdaq: PPD), a leading global contract research organization, today reported its financial results for the fourth quarter and full year ended December 31, 2020.
Highlights
Fourth... |
- | PPD and Clinical Ink Collaborate on Innovative Process for Lupus Assessment and Near Real-Time Access to Endpoint Data | WILMINGTON, N.C.--(BUSINESS WIRE)--Mar 24, 2021--
PPD, Inc. (Nasdaq: PPD ), a leading global contract research organization, and Clinical Ink, a global clinical technology company, have jointly developed a systemic lupus erythematosus (SLE)... |
- | PPD Lights Up Headquarters Downtown for 2021 Rare Disease Day | --(BUSINESS WIRE)--Feb 26, 2021--
PPD:
WHAT: Rare Disease Day takes place on the last day of February because it is a month known for having a “rare” number of days. This annual event serves to raise awareness among the general public and d... |